10 scientific trials to view in the first 50 % of 2025 Envisioned readouts in diabetes, cancer and depression headline a number of examine final results that might help the biotechnology sector get back its footing after a shaky year.No, Tirzepatide is not really insulin. It's really a GLP-1 and GIP receptor agonist that can help regulate blood sug